Opioids Flashcards

1
Q

Types of Opioids?

A
  1. Exogenous

2. Endogenous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Exogenous opioids?

A
  1. Synthesis: Natural, semisynthetic & synthetic

2. Receptor binding: Agonist, partial agonist, antaginists and biased agonists.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Action of opioids?

A

On receptors / Peptides

  1. Mu opioid receptors (M1,M2 & M3)
  2. Kappa opoioid receptor
  3. Delta opioid receptor
  4. Ophanin FQ/Nociceprion receptor (Not sensitive not naloxone)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Mu opioid receptors?

A
  1. M1 - Involved in opioid analgesia
  2. M2 - Opioid induced respiratory depression
  3. M3 - Opioid induced immune suppression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Classes of endogenous opioid receptors?

A
  1. Enkephalins
  2. Endorphines
  3. Dynorphins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Affinity of endogenous opioids?

A
  1. B-endorphins - MOR
  2. Met & Leu - enkephalins - KOR
  3. Dynorphins - DOR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Regulatory functions of endogenous opioids?

A
  1. Nociception, stress, emotion and hedonic responses

2. Thermoregulation, breathing, neuroendocrine function, GI motility and immune responses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Naturally occuring exogenous opioids ?

A
  1. Morphine
  2. Codeine
  3. Papaverine
  4. Thebaine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Semi-synthetic exogenous opioids ?

A
  1. Heroin
  2. Dihydromorphine, morphinone
  3. Thebaine derivatves (bruprenorphine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Synthetic exogenous opioids ?

A
  1. Morphinan derivatives (Levophanol, bulorphanol)
  2. Diphenylpropylamine derivatives ( Methadone)
  3. Benzomorphan derivatives (Pentazocine)
  4. Phenylpiperidine derivatives (Meperidine, fentanyl, sufentanil, alfentanil, remifentanil)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Classification according to opioid EC(50) - Plasma concentration at which they exert their effect ?

A
  1. Strong opioids: Alfentanil, fentanyl, sufntanil and remifentanil
  2. Intermediate: Morphine, Methadone, Oxycodone, hydromorphine and buprenorphine
  3. Weak opioids: Codeine, hydrocodeine, dextropropoxyphene and tramadol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Opioid agonists ? ( Full agonists)

A

Morphine, codeine, meperidine, fentanyl, sufentanil, remifentanil, methadone, tramadol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Opioid agonist/antagonist & Partial agonists?

A

Pentazocine, nalbuphine, butorphanol, buprenorphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Opioid antagonists ? -

No effect alone but reverses the effects of all agonists.

A

Nalorphine, naloxne, naltrexone, naltrindole, nalmefene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Opioid “Biased” agonists?

A

Oliceridine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Inverse agonists ?

A

Reduces basal receptor activity, drawing an inverse sigmoid. E.g; Naloxone, Naltrexone

17
Q

Mechanism of action of opioids?

A
  1. Peripheral mecahnism - Local release of endogenous opioid like substances that act on opioid receptors located on the primary sensory neuron
  2. Direct inhibition of ascending transmission of nociceptive information from spinal cord dorsal horn.
  3. Activating pain control pathways descending fromt he midbrain via the rostral ventromedial medulla (RVM) to the spinal cord dorsal horn
18
Q

Sequence after agonist binding to opioid receptor?

Left - G-protein signalling pathway:

A
  1. Dissociation of G-protein into alpha, beta & gamma subunits
  2. Inactivation of calcium channels
  3. Activation of potassium channels - Reducing excitability of the cell membrane
  4. Inhibition of adenyl cyclase
  5. Stimulation of mitogen associated protein kinases (MAPKs)
  6. Analgesia
19
Q

Right - B-arrestin signalling pathway:

Associated with side effects

A
  1. G-protein receptor kinases phosphorylate active G-protein coupled receptors enabling the recruitment of of B-arrestins
  2. Activation of MAPKs
20
Q

New opioid - Oliceridine ?

A
  1. IV MOR biased selective G-protein agonist
  2. Selectvely activates G-protein and B-arrestin signalling pathway
  3. Preference of G-protein over B-arrestin relative to morphine and fentanyl - Fewer side effects
  4. Hepatic metabolism with no metabolites
  5. No dose adjustment in patients with renal impairment.
  6. Potency equal to morphine
21
Q

New opioid - Tapentadol?

A
  1. Activates the Mu opioid receptor at the spinal and supraspinal sites also norepinephrine reuptake inhibitors (NRI).
  2. Affinity for MOR is 50 folds higher than that of morphine
  3. Lower side effects
22
Q

Pharmacokinetics of Opioids ?

A
  1. Weak bases

2. Dissociate to ionized and base fraction

23
Q

Ionized fraction of injected opioid?

A
  1. Less lipid soluble
  2. Attached to plasma protein and not available to diffuse to the action site.
  3. Ionized form is the effective form of molecule. The receptor recognizes the ionized form.
24
Q

Base fraction (free) of injected opioids?

A
  1. More lipid soluble and diffuses to action site.
25
Q

Lipophilic opioids ? Fentanyl / Sufentanil ( High volume of distribution)

A
  1. Low protein binding
  2. High volume of distribution
  3. Redistribution accounts for loss of analgesic effect in drugs with high vD
26
Q

Low volume of distribution ? Remifentanil / Alfentanil

A
  1. Low volume of distribution
  2. High clearance ( Remifentanil)
  3. High protein binding (Alfentanil)
  4. Clearance is responsible for the drop in plasma concentration (short duration of action).
27
Q

Opioid metabolism?

A
  1. Morphine > Morphine-6-Glucuronide & Morphine-3-Glucuronide (Active)
  2. CYP-3A4 & CYP-2D6 are involved in metabolism of; Heroin, Codeine, Fentanyl
  3. Genetic variability - Increased & decreased activity of CYP-2D6
  4. Remifentanil metabolized within erythrocyte and tissue non-specific esterases.
  5. Excreted by kidney or billiary tract into the gut. CKD can lead to accumulation and adverse effects (seizures & CNS depression)
28
Q

Context sensitive half-life ?

A

Read about this from textbook

29
Q

Biased agonists?

A

Read about mechanism of action